You are not authorized to access this page.
Search Within

Igor Odintsov

Formats
  1. Journal Article (16)
  2. Meeting Abstract (6)
  3. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (23)
  2. Department of Pathology and Laboratory Medicine (21)
  3. GSK Faculty (21)
  4. Human Oncology and Pathogenesis Program (21)
  5. Tow Center for Developmental Oncology (TCDO) (21)
  6. Department of Medicine (11)

More Groups

People
  1. Marc Ladanyi (21)
  2. Romel Somwar (21)
  3. Elisa De Stanchina (15)
  4. Inna Khodos (13)
  5. Marissa Mattar (13)
  6. Jo Weng Allan Lui (10)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (7)
  4. 2021 (8)
  5. 2020 (3)
  6. 2019 (1)
Publications
  1. Cancer Research (4)
  2. Journal of Thoracic Oncology (3)
  3. Clinical Cancer Research (2)
  4. Disease Models & Mechanisms (2)
  5. JCO Precision Oncology (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (4)
  4. Company of Biologists (2)
  5. AEPress, s.r.o. (1)
  6. Cold Spring Harbor Laboratory Press (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation
    Journal Article

    Choo, F.; Odinstov, I.; Nusser, K.; Nicholson, K. S.; Davis, L.; Corless, C. L.; Stork, L.; Somwar, R.; Ladanyi, M.; Davis, J. L.; more...
    Cold Spring Harbor Molecular Case Studies (2022)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1 fusion positive lung cancers
    Meeting Abstract

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Sato, H.; Siau, E.; Drilon, A.; Riely, G. J.; Somwar, R.; Ladanyi, M.; Davare, M. A.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Preclinical activity of seribantumab in gastrointestinal cancers with NRG1 fusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J.; Bloom, P. R.; Vojnic, M.; Leland, S.; Ladanyi, M.; Somwar, R.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The HER2xHER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions
    Meeting Abstract

    Odintsov, I.; Khodos, I.; Espinosa-Cotton, M.; Lui, A. J.; Mattar, M.; Schram, A. M.; Schackmann, R. C.; Lammerts van Bueren, J.; Geuijen, C. A.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Novel preclinical patient-derived lung cancer models reveal inhibition of HER3 and MTOR signaling as therapeutic strategies for NRG1 fusion-positive cancers
    Journal Article

    Odintsov, I.; Mattar, M. S.; Lui, A. J. W.; Offin, M.; Kurzatkowski, C.; Delasos, L.; Khodos, I.; Asher, M.; Daly, R. M.; Rekhtman, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • The anti-HER3 mAb seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions
    Journal Article

    Odintsov, I.; Lui, A. J. W.; Sisso, W. J.; Gladstone, E.; Liu, Z.; Delasos, L.; Kurth, R. I.; Sisso, E. M.; Vojnic, M.; Khodos, I.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Therapeutic potential of NTRK3 inhibition in desmoplastic small round cell tumor
    Journal Article

    Ogura, K.; Somwar, R.; Hmeljak, J.; Magnan, H.; Benayed, R.; Momeni Boroujeni, A.; Bowman, A. S.; Mattar, M. S.; Khodos, I.; de Stanchina, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation
    Journal Article

    Hayashi, T.; Odintsov, I.; Smith, R. S.; Ishizawa, K.; Liu, A. J. W.; Delasos, L.; Kurzatkowski, C.; Tai, H.; Gladstone, E.; Vojnic, M.; more...
    Disease Models & Mechanisms (2021)

    Fulltext@MSK | Save
  • ROS1 at the crossroads of clinical oncology, molecular diagnostics, and drug development
    Editorial

    Odintsov, I.; Somwar, R.; Ladanyi, M.; Drilon, A.
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Landscape of targetable alterations discovered by next generation sequencing demonstrates the role a community hospital can play in precision-guided oncology: Experience from Lenox Hill Hospital
    Meeting Abstract

    Vojnic, M.; Steinberg, J.; Odintsov, I.; Ziemba, Y.; Hill, L. K.; Vele, O.; Brunckhorst, K. R.; Hasanovic, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save